Relief 2g rectal suppositories 12s

The instruction for medical use

of Relif® medicine
the Trade name
of Relif®
the International unlicensed

name Fenilefrin Lekarstvennaya a form
Suppositories rectal
Structure
1 suppository contains
active agent: Phenylephrinum hydrochloride of 5 mg,
excipients: cocoa butter (teobromovy oil), methylparahydroxybenzoate, propilparagidroksibenzoat, starch corn.
The description
Evenly opaque, from pale white till light yellow color suppositories, a torpedo-shaped form.
Pharmacotherapeutic group
Vasoprotectives. Means for treatment of hemorrhoids and anal cracks for topical administration. Other means for treatment of hemorrhoids and anal cracks for topical administration.
The ATX C05AX code
Pharmacological properties
of Fenilefrin a hydrochloride is alpha adrenomimetikom, has local vasoconstrictive effect that promotes reduction of exudation and puffiness of fabrics, an itching, serous discharges in hemorrhoids and other diseases of an anorectal zone.
The drug Relif has the calming effect in the itching, burning, discomfort connected with hemorrhoids.
Indications
– external and internal hemorrhoids
– cracks, an erosion and microtraumas of an anus
– an anal itching
the Route of administration and doses
to use Drug after holding hygienic procedures. To enter into a rectum on 1 suppository to 4 times a day (in the morning, for the night and after each bowel emptying). The maximum daily dose – 4 suppositories. Duration of a course of treatment – 7-10 days.
Side effect
allergic reactions
of the Contraindication
– the increased individual sensitivity to drug ingredients
– a clotting disease
– a granulocytopenia Are possible
–
Medicinal interactions
Drug it is not necessary to appoint children's age up to 12 years along with MAO inhibitors, tricyclic antidepressants and antihypertensive drugs.
Special instructions
In cases of plentiful bloody discharges from an anus or at preservation of painful symptoms more than 7 days it is necessary to consult in addition with the proctologist.
Pregnancy and a lactation
during pregnancy and a lactation the prescribing of drug is possible only after careful assessment of a ratio advantage / risk both for mother, and for a fruit or the child.
The feature of influence on ability to run transport or potentially dangerous mechanisms
does not influence.
Overdose
Symptoms: in cases of significant exceeding the recommended single and daily doses the tendency to hypercoagulation can be observed.
Treatment: symptomatic.
A form of release and packing
On 6 suppositories in blister strip packaging from a film polyvinylchloride / polyethylene.
On 2 planimetric packs together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.

To Store storage conditions at a temperature not above 25 °C.
To store out of children's reach!
Period of storage
2 years.
Not to use upon termination of the expiration date specified on packing.
Prescription status
Without prescription.
Name of manufacturing firm, country of the producer,
address Istituto De Angeli of Neuter of l., 50066 Reggello (Florence), Locke. Prulli 103/with, Italy
the Name and the country of the owner of the registration certificate
of Bayer Konsyyumer Ker AG, Switzerland
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of the products (goods) and responsible for post-registration observation of safety of medicine:


TOO Bayer KAZ Timiryazev St., 42, business center Expo-City, peahens. 15
050057, Almaty, Republic of Kazakhstan
Ph.: + 7 (727) 258 80 40
Fax: + 7 (727) 244 70 01
e-mail: kz.claims@bayer.com